Future of the Antimicrobial Susceptibility Testing Market: Strategic Analysis and Forecast to 2034

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Antimicrobial Susceptibility Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for antimicrobial susceptibility testing has seen a significant expansion in recent years. Starting from a value of $4.36 billion in 2024, it's projected to increase to $4.66 billion in 2025. This represents a compound annual growth rate (CAGR) of 7.1%. The growth experienced in the past period can be accredited to a number of factors, namely heightened healthcare spending, an aging demographic, increased awareness and education, regulatory backing, and economic prosperity.

Antimicrobial Susceptibility Testing Market Size Forecast: What's the Projected Valuation by 2029?
The market for antimicrobial susceptibility testing is projected to experience robust expansion in the upcoming years. With an estimated compound annual growth rate (CAGR) of 5.7%, the market is set to hit $5.81 billion by 2029. The expansion during the predicted period is likely to be driven by factors such as the growing occurrence of drug-resistant infections, advancements in healthcare infrastructure, increased focus on drug discovery, and rising disposable income. Key trends forecasted for the same period are the utilization of automation and robotics, AI and machine learning, multiplexing, integration of telemedicine, and rapid ast methodology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/antimicrobial-susceptibility-testing-global-market-report

What Are the Drivers Transforming the Antimicrobial Susceptibility Testing Market?
The escalation of infectious diseases worldwide has fueled the expansion of the antimicrobial susceptibility testing market. These ailments are precipitated by entities such as bacteria, viruses, fungi, and parasites. Illnesses attributed to bacteria encompass bacterial pneumonia and tuberculosis, while viral diseases include smallpox, AIDS, among others. For illustration, data from The Centers for Disease Control and Prevention, a US-based national public health institution, indicated that in 2023, out of 9,573 TB cases where the birth origin was identifiable, 7,259 (76%) were recorded among non-U.S.-born individuals. This presents an 18% uptick compared to the 6,177 cases reported in the previous year, 2022. Consequently, this escalating prevalence of infectious diseases is propelling the growth of the antimicrobial susceptibility testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4026&type=smp

What Long-Term Trends Will Define the Future of the Antimicrobial Susceptibility Testing Market?
The escalating use of rapid antimicrobial susceptibility testing to prevent antibiotic misuse and ensure effective treatment is becoming an important trend in the antimicrobial susceptibility testing market. Numerous methods exist which can conduct these tests in a matter of minutes or a few hours. FISH (Fluorescence in situ hybridization) is often employed in this accelerated testing. Utilizing peptide nucleic acid probes, the PNA-FISH approach enables swift and precise binding, a procedure exploited in QuickFish technology from OpGen. This technique identifies microorganisms by targeting 16s RNA. For example, Genefluidics Inc's antimicrobial susceptibility testing system measures bacterial growth by tallying 16s rRNA molecules through an electrochemical biosensor.

Which Segments in the Antimicrobial Susceptibility Testing Market Offer the Most Profit Potential?
The antimicrobial susceptibility testing market covered in this report is segmented -

1) By Type: Antibacterial Testing, Antifungal Testing, Antiparasitic Testing, Other Types
2) By Products: Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Consumables
3) By Application: Diagnostics, Drug Discovery and Development, Epidemiology, Other Applications
4) By End User: Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Clinical Research Organizations (CROs)

Subsegments:
1) By Antibacterial Testing: Disk Diffusion Method, Broth Dilution Method, E-Test Method, Automated Systems
2) By Antifungal Testing: Broth Dilution Method, Agar Disk Diffusion Method, E-Test Method, Colorimetric Methods
3) By Antiparasitic Testing: In vitro Susceptibility Testing, Microscopic Examination, Molecular Methods
4) By Other Types: Mycobacterial Susceptibility Testing, Biofilm Susceptibility Testing, Combination Antimicrobial Testing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=4026&type=smp

Which Firms Dominate the Antimicrobial Susceptibility Testing Market by Market Share and Revenue in 2025?
Major companies operating in the antimicrobial susceptibility testing market include BioMérieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Accelerate Diagnostics Inc., Hi-Media Laboratories, Creative Diagnostics, Merck KGaA, Roche Diagnostics Limited, Alifax Holding S.p.A., Synbiosis Ltd., Zhuhai DL Biotech Co. Ltd., Mast Group Ltd., ELITechGroup, Genefluidics Inc., Condalab, QuantaMatrix Inc., Bruker Corporation, Eurofins Scientific SE, Liofilchem s.r.l., Hardy Diagnostics, Micromax Technologies, Bioanalyse GmbH, Lab M Limited, Microbiologics Inc., Quidel Corporation, R-Biopharm AG, SSI Diagnostica A/S, VWR International LLC, ZeptoMetrix Corporation

Which Regions Offer the Highest Growth Potential in the Antimicrobial Susceptibility Testing Market?
North America was the largest region in the antimicrobial susceptibility testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the antimicrobial susceptibility testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4026

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.